Clinical Trial Update: A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating intramyocardial injection of human umbilical cord mesenchymal stem cells (HucMSCs) for the treatment of chronic heart fai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ischemic Cardiomyopathy

Drugs mentioned

• HucMSCs (human umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Tasly Pharmaceutical Group Co., Ltd | Conditions: Coronary Artery Bypass Grafting (CABG), Chronic Heart Failure | Phase 1, Phase 2 | Status: RECRUITING